These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 304924)

  • 1. [Evaluation of sclerosis treatment based on blood circulation or vascular lesions].
    Takeda K; Shigemi F; Shiraishi S; Nagai T; Kuwabara A
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):778-81. PubMed ID: 304924
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic therapy for progressive systemic sclerosis and tissue fibrinolytic activity in affected skin.
    Shigemi F; Fujita T; Ohsaki M; Shiraishi S
    J Dermatol; 1978 Jun; 5(3):135-8. PubMed ID: 353113
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on blood coagulation and fibrinolytic activities in the cases of cerebral infarction treated with urokinase. 2nd Report -- espeically changes of coagulofibrinolytic system before and after UK infusion (author's transl)].
    Fujita S; Shou T; Yamamoto H; Ishikawa H; Itoga T
    Rinsho Ketsueki; 1979 Jul; 20(7):745-53. PubMed ID: 501999
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental and clinical studies on thrombolytic therapy with urokinase.
    Shiba T; Igarashi M; Takeuchi S; Awazu S; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Aug; 41(4):771-81. PubMed ID: 82362
    [No Abstract]   [Full Text] [Related]  

  • 5. [Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy].
    Brochier M; Planiol T; Griguer P; Raynaud P; Fauchier JP; Charbonnier B; Latour F; Pellois A
    Coeur Med Interne; 1977; 16(4):513-21. PubMed ID: 589966
    [No Abstract]   [Full Text] [Related]  

  • 6. [The fibrinolytic therapy in renal disease (author's transl)].
    Kaburagi T; Yokoyama S; Tanaka K; Haniu T; Suzuki T; Mithunami K; Takayama S; Oguma S; Hatori T; Kishimoto T; Tomimoto K
    Nihon Jinzo Gakkai Shi; 1980 Jan; 22(1):59-79. PubMed ID: 6991744
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of various collagen diseases based on connective tissue metabolism--with special reference to systemic scleroderma].
    Sasaki M
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):774-7. PubMed ID: 304922
    [No Abstract]   [Full Text] [Related]  

  • 8. [Indications and results of thrombolytic treatment with urokinase of very severe pulmonary embolism].
    Brochier M; Raynaud R; Griguer P; Faucchier JP; Morand P
    Boll Soc Ital Cardiol; 1973; 18(7):693-6. PubMed ID: 4620067
    [No Abstract]   [Full Text] [Related]  

  • 9. [Problems in urokinase therapy in cerebral infarction].
    Matsuo T; Matsuo O
    Rinsho Ketsueki; 1978 Oct; 19(10):1475-8. PubMed ID: 739610
    [No Abstract]   [Full Text] [Related]  

  • 10. [Urokinase treatment of threatened and acute myocardial infarct].
    Babeau P; Pras P
    Ann Med Interne (Paris); 1977 Feb; 128(2):219-25. PubMed ID: 869389
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urokinase, an expensive false development of thrombolytic therapy].
    von Kaulla KN
    Dtsch Med Wochenschr; 1976 Oct; 101(42):1543-5. PubMed ID: 976121
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urokinase (in situ) in the case of acute ischemia of the lower limbs (author's transl)].
    Paillot J; Dumontier P; Raynov M; Ott B; Benichoux R
    J Mal Vasc; 1981; 6(1):19-22. PubMed ID: 7026712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive vascular disease treated by urokinase.
    Mazel MS; Riera R
    Med Trial Tech Q; 1979; 25(3):319-31. PubMed ID: 423742
    [No Abstract]   [Full Text] [Related]  

  • 14. Is the hypotensive action of urokinase beneficial for thrombolytic therapy?
    Matsuo O; Kosugi T; Mihara H
    Thromb Haemost; 1978 Apr; 39(2):526-7. PubMed ID: 580999
    [No Abstract]   [Full Text] [Related]  

  • 15. Retrospective study on the efficacy of using urokinase therapy.
    Matsuo O; Kosugi T; Mihara H; Ohki Y; Matsuo T
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):684-8. PubMed ID: 506651
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of acute pulmonary emboli with urokinase in high doses. Apropos of 20 cases].
    Page A; Conri C; Blanc A; Lorient MF; Boisseau M; Besse P
    Coeur Med Interne; 1979; 18(2):293-300. PubMed ID: 487718
    [No Abstract]   [Full Text] [Related]  

  • 17. [A study on the urokinase treatment in patients with glomerulonephritis and nephrotic syndrome].
    Konishi K; Kato E; Iyori S; Higashi F
    Nihon Jinzo Gakkai Shi; 1982 Apr; 24(4):429-44. PubMed ID: 6750187
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical improvement in systemic sclerosis resulting from urokinase therapy explained by light and electron microscopy skin examination.
    Bazzichi L; Rossi A; De Giorgio F; Gesi M; Lenzi P; Pellegrini A
    Scand J Rheumatol; 2003; 32(5):261-7. PubMed ID: 14690137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subconjunctival injection of urokinase in the treatment of diabetic vitreous hemorrhage].
    Chen XL
    Zhonghua Yan Ke Za Zhi; 1983 Jan; 19(1):35-6. PubMed ID: 6406190
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal urokinase in the treatment of vitreous haemorrhage.
    Cleary PE; Davies EW; Shilling JS; Hamilton AM
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):587-90. PubMed ID: 4534195
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.